Phase 2 Multiple-Dose Metastatic Castration-Resistant Prostate Cancer

People with Metastatic Castration-Resistant Prostate Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

• Are a male or female at least 18 years of age
• Have histologically confirmed diagnosis of carcinoma of the prostate
• Have prostate cancer that has progressed after treatment with at least 2 prior lines
• Have evaluable disease
• Have adequate archival metastatic tumor tissue or agree to undergo a biopsy of at least 1 metastatic site

You may NOT participate in this study if you:

• Are currently receiving anticancer therapies other than androgen deprivation therapy
• Have had treatment with any other anticancer therapy within 2 weeks of the start of study drug
• Have known active central nervous system metastases and/or carcinomatous meningitis
• Have active known or suspected autoimmune disease
• Have history or evidence of any other clinically unstable/uncontrolled disorder, condition, or disease
• Have known immunodeficiency virus (HIV) infection or hepatitis C
• Have a positive test for HBsAg or HBcAb
• Are pregnant or breastfeeding

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Rd, 5th floor Room # 503,
Bronx, NY-10461
Phone: (718) 405-8209